Research Article
Integrating Network Pharmacology and Experimental Validation to Elucidate the Mechanism of Yiqi Yangyin Decoction in Suppressing Non-Small-Cell Lung Cancer
Figure 7
YYD inactivates EGFR-PI3K-AKT signaling in NSCLC cells. (a, b) Effects of YYD (0, 125, and 250 μg/ml) on the expression levels of p-EGFR, EGFR, p-PI3K, PI3K, p-AKT, and AKT were determined with western blot assays. , , and versus the nontreated group.
(a) |
(b) |